FDA Announces Guidance for Reducing T. cruzi Infection Risk in Blood Transfusions

Summary

The FDA has released a guidance document outlining the use of serological tests to detect antibodies to Trypanosoma cruzi in whole blood and blood components intended for transfusion, aiming to reduce the risk of T. cruzi infection transmission